About this trial
1. To determine the susceptibility pattern of our local isolated Candida strains which is essential for optimal management of fungal infection. 2. Detection of biofilm formation by conventional and molecular methods 3. Comparison between C. albicans and non-albicans in the prevalence of biofilm formation and biofilm -forming genes 4. Find the association between antifungal resistance and biofilm formation in candida strains isolated from patients 5. Determination of clinical factors associated with occurrence of infections.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Patients who received antifungal therapy within 3 days prior to sample collection.
Resistant to antibiotic therapy.
Trial population
patients admitted to hematology intensive care
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
To asses the prevalence of candida species as a cause of infection in patient in hematology intinsive care unit
To asses the prevalence of genes responsible for biofilm formation in different candida species
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: